<html><head><title>IMMZ.D5.DT.Malariacontraindications</title><link rel="stylesheet" type="text/css" href="includes/dmn.css"/></head><body><table class="decision"><tr class="decision-header"><td class="row-label">Decision ID</td><td colspan="100"><span class="decision-id">IMMZ.D5.DT.Malariacontraindications</span><span class="decision-name">IMMZ.D5.DT.Malariacontraindications</span></td></tr><tr class="io-row"><td class="row-label">Inputs/Outputs</td><td class="input">Potential contraindications</td></tr><tr class="rule"><td class="row-label"/><td class="inputEntry">
          "Potential contraindications" = "Hypersensitivity to vaccine components"
          The client has hypersensitivity to any of the vaccine components
        </td><td class="outputEntry">
          "Immunization recommendation status" =  "Further evaluation needed"
          Malaria vaccination could be contraindicated. Clinical judgement is required. Create a clinical note
        </td><td class="outputEntry">
          Do not vaccinate client with RTS,S/AS01 vaccine if client has severe hypersensitivity to any of the vaccine components.
          Do not vaccinate client with RTS,S/AS01 vaccine if client has severe hypersensitivity to any of the vaccine components.
        </td><td class="annotationEntry">
          –
        </td><td class="annotationEntry">
          Malaria vaccine: WHO position paper (March 2022) (26)
        </td><td class="annotationEntry">
          –
        </td><td class="annotationEntry">
          Malaria vaccine: WHO position paper (March 2022) (26)
        </td></tr></table></body></html>